Page 23 - Vistagen Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vistagen therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vistagen Therapeutics Today - Breaking & Trending Today

StreetInsider.com - Analyst Comments

StreetInsider.com - Analyst Comments
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Edwards Lifesciences , Brookline Capital Markets Bullish On Syros Pharmaceuticals , Morgan Stanley , Amenovix Corporation , Wafer Starts Possibly Being Pushed Out , Reiterates Hold Rating , Cardiovascular Systems , Conference Commentary Positive , Analyst Day Highlights Fab Improvements , Market Potential , Capital Markets Bullish , Syros Pharmaceuticals , Buy Rating , Has Potential , Open Several New , Blair Reiterates Outperform Rating , Vistagen Therapeutics , Loop Capital , Inventory Levels Begin , Remains Bullish ,

Zacks: Analysts Expect VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Will Post Earnings of -$0.06 Per Share

Equities analysts expect VistaGen Therapeutics, Inc. (NASDAQ:VTGN – Get Rating) to report earnings per share of ($0.06) for the current quarter, Zacks reports. Two analysts have provided estimates for VistaGen Therapeutics’ earnings. VistaGen Therapeutics posted earnings per share of ($0.20) during the same quarter last year, which would suggest a positive year over year growth […] ....

United States , Vistagen Therapeutics Inc , Goldman Sachs Group Inc , Zacks Investment Research , Vistagen Therapeutics Company Profile Get Rating , Renaissance Technologies , America Corp , Vistagen Therapeutics , Get Rating , Vistagen Therapeutic , Gen Therapeutics , Sachs Group , Street Corp , Gen Therapeutics Company Profile , Nasdaq Vtgn ,

VistaGen to Participate in Upcoming June Investor Conferences

VistaGen to Participate in Upcoming June Investor Conferences
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New York , United States , Shawn Singh , Nate Hitchings , Mark Flather , William Blair , Vistagen Therapeutics Inc , Company Presentation , Annual Growth Stock Conference , Jefferies Global Healthcare , Gen Therapeutics , Chief Executive Officer , Fireside Chat , Central Time , Eastern Time , Investor Relations , Vistagen Therapeutics ,

AN2 Therapeutics, Inc (ANTX) Appoints Maggie FitzPatrick to Its Board

AN2 Therapeutics, Inc (ANTX) Appoints Maggie FitzPatrick to Its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Syracuse University , District Of Columbia , United States , Muriel Bowser , Eric Easom , Maggie Fitzpatrick , Dc Commission , Foundation At Cigna , Council Of The District Columbia , National Association Of Corporate Directors , Harvard Business School , Therapeutics Inc , George Washington University , Chief Executive Officer , Before Johnson , Chief Communications Officer , Vistagen Therapeutics , Washington Business Journal , Public Policy , George Washington , National Association , Mayor Muriel Bowser , Vice Chairperson ,

UPDATE: VistaGen says regulators couldn't sniff out abuse potential of its nasal spray for social anxiety

VistaGen Therapeutics is one step closer to launching its nasal spray for social anxiety after the FDA said it does not need an additional study testing the drug's potential to be abused. ....

Vistagen Therapeutics , Neurological Disorders , Food And Drug Administration Fda , Clinical Trial , Fierce Biotech Homepage ,